Dashboard
Manage Tickers

TSX:FTRPna


na (na)    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 482.58 $ 0.66 (0.14 %)
DIA $ 391.46 $ 0.00 (0 %)
SPY $ 545.45 $ 0.11 (0.02 %)
TLT $ 90.47 $ -0.20 (-0.22 %)
GLD $ 215.21 $ -0.06 (-0.03 %)
$ na
-- x --
-- x --
-- - --
na - na
0
na
na
na
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
Field Trip Announces Closing Of Plan Of Ar...
08/12/2022 19:21:26

- Field Trip Health Ltd. has been renamed "Reunion Neuroscience Inc." and remains listed on the NASDAQ Stock Market and...

field-trip-shares-fiscal-q4-and-full-year-2022-results--update-on-court-approved-corporate-reorganization
Field Trip Shares Fiscal Q4 And Full Year ...
07/01/2022 00:34:47

Psychedelic therapies developer and provider Field Trip Health Ltd.

field-trip-and-cerebral-partner-to-bring-together-teletherapy-telepsychiatry-and-psychedelic-assisted-therapy
Field Trip And Cerebral Partner To Bring T...
03/03/2022 14:43:01

field-trip-health-posts-330-yoy-increase-in-q3-revenue
Field Trip Health Posts 330% YoY Increase ...
02/16/2022 15:30:50

Psychedelics company Field Trip Health Ltd. (TSX: FTRP) (NASDAQ: FTRP) reported its third fiscal quarter 2022 results for the t...

Core News & Articles
Field Trip Health Reports Received Notice ...
01/11/2022 15:02:36

Field Trip Health Ltd. (NASDAQ:FTRP, TSX:FTRP) ("Field Trip"), a global leader in the development and delivery of psych...

elon-musk-acknowledges-therapeutic-potential-of-psychedelic-drugs-will-this-impact-the-markets
Elon Musk Acknowledges Therapeutic Potenti...
09/29/2021 18:49:44

Elon Musk expressed his support for the therapeutic potential of psychedelic drugs. The Space X and Tesla (NASDAQ: TSLA) CEO s...

psyched-field-trip-uplists-to-nasdaq-mindmed-to-study-dmt-atai-launches-new-subsidiary-aocs-psychedelics-amendment-rejected
Psyched: Field Trip Uplists To Nasdaq, Min...
08/02/2021 14:08:33

Last week in Psychedelics:

field-trip-health-debuts-on-nasdaq-with-average-performance-looks-to-expand-footprint-of-psychedelics-clinics
Field Trip Health Debuts On Nasdaq With Av...
07/29/2021 19:37:13

Field Trip Health (TSX: FTRP) (NASDAQ: FTRP) made its Nasdaq debut on Thursday, becoming the fifth company in the psychedelics ...

field-trip-health-heads-to-the-nasdaq-as-wall-street-opens-up-to-psychedelics-renaissance
Field Trip Health Heads To The Nasdaq As W...
07/23/2021 21:04:15

Excitement around psychedelics grows as major U.S. exchanges make room for more companies in the sector.

palo-santo-new-venture-capital-group-raises-35m-to-focus-on-psychedelic-medicine
Palo Santo: New Venture Capital Group Rais...
07/15/2021 18:46:01

Palo Santo, a newly-created venture capital fund with an eye on psychedelic medicines, announced its official launch on Thursday.

Core News & Articles
Roth Capital Initiates Coverage On Field T...
06/15/2021 12:43:31

Roth Capital analyst Elemer Piros initiates coverage on Field Trip Health (TSX:FTRP) with a Buy rating and announces Price T...

psyched-atais-214m-ipo-mindmed-ceo-resigns-field-trip-applies-to-nasdaq-cybin-and-novamind-target-frontline-health-workers
Psyched: Atai's $214M IPO, MindMed CEO Res...
06/14/2021 13:18:12

Atai Launches $214 Million Nasdaq IPO Offering Psychedelics biotech platform Atai life Sciences has announced an initial publi...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)
07/16/2024 Teladoc Health, Inc. (TDOC)
07/16/2024 Vestis Corporation (VSTS)
07/22/2024 Cambium Networks Corporation (CMBM)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)